Preparation of Poloxamer188-b-PCL and Study on in vitro Radioprotection Activity of Curcumin-Loaded Nanoparticles

被引:18
作者
Lin Xiaona [1 ]
Shi Yongli [2 ]
Yu ShaSha [2 ]
Li Siyi [2 ]
Li Wenhui [2 ]
Li Meishuang [2 ]
Chen Shengxi [2 ]
Wang Yuanbo [2 ]
Cong Mei [2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Tianjin Key Lab Radiat Med & Mol Nucl Med, Inst Radiat Med, Tianjin, Peoples R China
[2] Xinxiang Med Univ, Coll Pharm, Xinxiang, Henan, Peoples R China
基金
美国国家科学基金会;
关键词
poloxamer188-b-PCL; nanoparticles; antioxidant activity; curcumin; caner radiotherapy; ANTI-HYPERLIPIDEMIA; ANTITUMOR-ACTIVITY; STABILITY; DELIVERY; ANTIOXIDANT; CANCER; IMPACT; ENHANCEMENT; INHIBITION; AGENT;
D O I
10.3389/fchem.2020.00212
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A novel polymer of poloxamer188-b-PCL was synthesized via a ring-opening polymerization. Fourier transform infrared spectroscopy (FTIR), Raman, and H-1 nuclear magnetic resonance (H-1 NMR) spectra were used to study the structures of obtained poloxamer188-b-PCL. The thermo-stability of poloxamer188 -b-PCL was carried out with a thermal gravimetric analyzer (TGA), and cytotoxicity was obtained using the CCK8 method. Cargo-free and curcumin (CUR)-loaded poloxamer188-b-PCL NPs were fabricated via the solvent evaporation method. The morphology, particle size distribution, and stability of cargo-free NPs were studied with a scanning electron microscope (SEM) and laser particle analyzer. The in vitro radioprotection activity of CUR-loaded NPs was performed. FTIR, Raman, and H-1 NMR spectra confirmed that poloxamer188-b-PCL was obtained. TGA curves suggested poloxamer188-b-PCL had better thermo-stability than original poloxamer188. Cell tests suggested that the cargo-free NPs had no cytotoxicity. SEM image showed that the cargo-free NPs were spherical with a diameter of 100 nm. Free radical scavenging experiments proved that CUR-loaded NPs had better antioxidant activity than CUR solutions. CUR-loaded NPs could be detected in all tissues, including liver, kidneys and lung. In summary, this work demonstrated a feasibility of developing an injective formulation of CUR and provided a protection agent in caner radiotherapy.
引用
收藏
页数:11
相关论文
共 43 条
[1]  
Abdelrazek E.M., 2016, Egypt. Int. J. Basic Appl. Sci., V3, DOI [10.1016/j.ejbas.2015.06.001, DOI 10.1016/J.EJBAS.2015.06.001]
[2]   Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases [J].
Aggarwal, Bharat B. ;
Harikumar, Kuzhuvelil B. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (01) :40-59
[3]   Curcumin administration suppress acetylcholinesterase gene expression in cadmium treated rats [J].
Akinyemi, Ayodele Jacob ;
Oboh, Ganiyu ;
Fadaka, Adewale Oluwaseun ;
Olatunji, Babawale Peter ;
Akomolafe, Seun .
NEUROTOXICOLOGY, 2017, 62 :75-79
[4]   Development and characterization of methoxy poly (ethylene oxide)-block-poly(ε-caprolactone) (PEO-b-PCL) micelles as vehicles for the solubilization and delivery of tacrolimus [J].
Ali, Raisuddin ;
Farah, Abubakar ;
Binkhathlan, Ziyad .
SAUDI PHARMACEUTICAL JOURNAL, 2017, 25 (02) :258-265
[6]   INHIBITION OF RED BLOOD CELL-INDUCED PLATELET-AGGREGATION IN WHOLE-BLOOD BY A NONIONIC SURFACTANT, POLOXAMER 188 (RHEOTHRX(R) INJECTION) [J].
ARMSTRONG, JK ;
MEISELMAN, HJ ;
FISHER, TC .
THROMBOSIS RESEARCH, 1995, 79 (5-6) :437-450
[7]   Dried prickly pear cactus (Opuntia ficus indica) cladodes as a low-cost and eco-friendly biosorbent for dyes removal from aqueous solutions [J].
Barka, Noureddine ;
Ouzaouit, Khalid ;
Abdennouri, Mohamed ;
El Makhfouk, Mohammed .
JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS, 2013, 44 (01) :52-60
[8]   Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies [J].
Epstein, Jenny ;
Sanderson, Ian R. ;
MacDonald, Thomas T. .
BRITISH JOURNAL OF NUTRITION, 2010, 103 (11) :1545-1557
[9]  
Esatbeyoglu T, 2015, FOOD FUNCT, V6, P887, DOI [10.1039/c4fo00790e, 10.1039/C4FO00790E]
[10]  
Fadus Matthew C, 2017, J Tradit Complement Med, V7, P339, DOI 10.1016/j.jtcme.2016.08.002